Skip to main content
OpenTrials
Completed

NCT Number: NCT02642510

Improving Patient Education for Lymphoma and Leukemia Inpatients

The purpose of this study is to evaluate the impact of a structured, DVD educational intervention about what to expect during inpatient treatment of a newly diagnosed cancer. The focus of the study will be newly diagnosed lymphoma and acute leukemia patients and their family members. Outcome variables will be the patient and family member's satisfaction with inpatient teaching and anxiety about inpatient treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Leukemia Hematologic Diseases Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoma Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Emory University Hospital

Atlanta, Georgia, 30322, United States

About this study

The purpose of this study is to evaluate the impact of a structured, DVD educational intervention about what to expect during inpatient treatment of a newly diagnosed cancer. The focus of the study will be newly diagnosed lymphoma and acute leukemia patients and their family members. Outcome variables will be the patient and family member's satisfaction with inpatient teaching and anxiety about inpatient treatment.

The experimental group will watch a DVD educational presentation of information about unit routines and activities; leukemia/lymphoma; treatment modalities and procedures; treatment of side effects; and patient and family members activities of importance to prevent infection and promote well-being during cancer treatment.

Participants in the control group will receive usual educational teaching by their assigned nursing staff.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

For participants admitted for suspect diagnosis of leukemia or lymphoma:

  • Admission to the hematology/leukemia unit (6E) at Emory University Hospital with a suspected or actual new diagnosis of leukemia or lymphoma within the past 24 hours
  • English-speaking
  • Completed education to at least the 6th grade level
  • No significant auditory or visual deficits with corrective devices
  • No central nervous system involvement of disease
  • Physiologically stable
  • Not at end of life
  • No alterations in mental status
  • Agrees to family member (family member; significant other; friend) participation in study and to selecting the individual who could participate

For Family Members:

  • Willing to view DVD and read education booklet
  • Selected by patient to participate
  • English speaking
  • No significant auditory or visual deficits with corrective devices
  • No alterations in mental status
  • Completed education to at least the 6th grade level

Exclusion criteria

  • At end of life
  • Altered mental status
  • Significant auditory or visual deficits with corrective devices

Treatment and study plan

Structured Education DVD + Verbal Teaching

Other

The structured education DVD is a 15-minute DVD presentation of information about unit routines and activities; leukemia/lymphoma; treatment modalities and procedures; treatment of side effects; and participant and family members activities of importance to prevent infection and promote well-being during cancer treatment.

Participants will also receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.

Verbal Teaching

Other

Participants will receive verbal educational teaching by their assigned nursing staff regarding information about leukemia and lymphoma, common treatments, and side effects.

Primary outcomes

  1. Quality of Discharge Teaching Scale (QDTS) Score

    Time frame: Post Educational Teaching (Up to 30 minutes)

    Overall satisfaction will be measured with the Quality of Discharge Teaching Scale (QDTS).The QDTS is a 24 item survey to evaluate all of the teaching received by patients during their hospitalization prior to discharge. Each item on the survey is rated on a 0 to 10 numeric scale, with 0 representing an item was not addressed and 10 representing an item addressed a great deal. For each aspect of education or information being evaluated, participant are asked to rate the content of the education, as well as the delivery of the content.

Secondary outcomes

  1. Visual analog scale (VAS) Score

    Time frame: Post Educational Teaching (Up to 30 minutes)

    Participants are instructed to place a horizontal mark across the 100 mm vertical line anchored at one end with the words "No Anxiety" and at the other end "Worst Anxiety Imaginable" at the level of their anxiety about inpatient cancer treatment. Rating of anxiety for the study will be done by having the participant mark their anxiety level on a new, unmarked VAS. Scoring of the VAS is done by measuring in millimeters from the end of the vertical line with the anchor phrases of "no anxiety" to the intersection of the participant's mark on the vertical line. Possible scores on the VAS range from 0 to 100 millimeters with higher scores indicating higher levels of anxiety.

Sponsors and collaborators

Lead sponsor

Emory University

Other

Registry information

Official study title

Improving Patient Education for Newly Diagnosed Lymphoma and Acute Leukemia Inpatients

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Dec 30, 2015
Registry last updated
Jun 22, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.